1,003
Views
51
CrossRef citations to date
0
Altmetric
CONTENTS

Nano-TiO2 – feasibility and challenges for human health risk assessment based on open literature

, , , , , & show all
Pages 110-124 | Received 18 Dec 2009, Accepted 25 Jun 2010, Published online: 23 Aug 2010

References

  • Afaq F, Abidi P, Matin R, Rahman Q. 1998. Cytotoxicity, pro-oxidant effects and antioxidant depletion in rat lung alveolar macrophages exposed to ultrafine titanium dioxide. J Appl Toxicol 18(5):307–312.
  • Ahn MH, Kang CM, Park CS, Park SJ, Rhim T, Yoon PO, Chang HS, Kim SH, Kyono H, Kim KC. 2005. Titanium dioxide particle-induced goblet cell hyperplasia: Association with mast cells and IL-13. Respiratory Research 6:34–43.
  • Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin S, Peters S, Tran CL, Christensen FM. 2010a. Review on fullerene toxicity and exposure – appraisal of a human health risk assessment based on open literature. Reg Toxicol Pharm (Submitted).
  • Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin S, Peters S, Tran CL, Christensen FM. 2010b. Review on carbon nanotubes toxicity and exposure – appraisal of a human health risk assessment based on open literature. Crit Rev Toxicol (Accepted).
  • Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicolog Sci 77(2):347–357.
  • Boffetta P, Soutar A, Cherrie JW, Granath F, Andersen A, Anttila A, Blettner M, Gaborieau V, Klug SJ, Langard S, Luce D, Merletti F, Miller B, Mirabelli D, Pukkala E, Adami HO, Weiderpass E. 2004. Mortality among workers employed in the titanium dioxide production industry in Europe. Cancer Causes Control 15:697–706.
  • Boxall A, Chaudhry Q, Sinclair C, Jones A, Aitken R, Jefferson B, Watts C. 2007. Current and future predicted environmental exposure to engineered nanoparticles. Final client report by the Central Science Laboratory for Department of Environment Food and Rural Affairs (DEFRA).
  • Chen HW, Su SF, Chien CT, Lin WH, Yu SL, Chou CC, Chen JJ, Yang PC. 2006. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J 20(13):2393–2395.
  • Chen J, Dong X, Zhao J, Tang G. 2009. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol 29(4):330–337.
  • Chen JL, Fayerweather WE. 1988. Epidemiologic study of workers exposed to titanium dioxide. J Occupat Med (Official Pub Industrial Med Assoc) 30:937–942.
  • Christensen FM, Johnston HJ, Stone V, Aitken RJ, Hankin S, Peters S, Aschberger K. 2010. Nano-silver – feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 4:284–295.
  • Churg A, Gilks B, Dai J. 1999. Induction of fibrogenic mediators by fine and ultrafine titanium dioxide in rat tracheal explants. Am J Physiol 277(5):L975–982.
  • Duffin R, Tran L, Brown D, Stone V, Donaldson K. 2007. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: Highlighting the role of particle surface area and surface reactivity. Inhalat Toxicol 19(10):849–856.
  • Dussert AS, Gooris E, Hemmerle J. 1997. Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmetic Sci 19(3):119–129.
  • European Commission (EC). 2003. Technical Guidance Document in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. EC, Joint Research Centre. Available via the website: http://ecb.jrc.ec.europa.eu/tgd/.
  • European Chemicals Agency (ECHA). 2008. REACH Guidance on Information Requirements and Chemicals Safety Assessment. Available via the website: http://guidance.echa.europa.eu/.
  • Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, Van RB. 2008. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 82(3):151–157.
  • Ferin J, Oberdörster G, Penney DP. 1992. Pulmonary retention of ultrafine and fine particles in rats. Am J Respirat Cell Molec Biol 6(5):535–542.
  • Fryzek JP, Chadda B, Marano D, White K, Schweitzer S, McLaughlin JK, Blot WJ. 2003. A cohort mortality study among titanium dioxide manufacturing workers in the United States. J Occup Environ Med/Am Coll Occup Environ Med 45:400–409.
  • Gamer AO, Leibold E, Van RB. 2006. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 20(3):301–307.
  • Garabrant DH, Fine LJ, Oliver C, Bernstein L, Peters JM. 1987. Abnormalities of pulmonary function and pleural disease among titanium metal production workers. Scand J Work, Environ Health 13:47–51.
  • Grassian VH, Adamcakova-Dodd A, Pettibone JM, O'Shaughnessy PT, Thorne PS. 2007. Inflammatory response of mice to manufactured titanium dioxide nanoparticles: Comparison of size effects through different exposure routes. Nanotoxicology 1(3):211–226.
  • Gurr JR, Wang AS, Chen CH, Jan KY. 2005. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 213(1–2):66–73.
  • Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch W, Levsen K. 1995. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhalat Toxicol 7(4):533–556.
  • Helfenstein M, Miragoli M, Rohr S, Muller L, Wick P, Mohr M, Gehr P, Rothen-Rutishauser B. 2008. Effects of combustion-derived ultrafine particles and manufactured nanoparticles on heart cells in vitro. Toxicology 253(1–3):70–78.
  • Hext PM, Tomenson JA, Thompson P. 2005. Titanium dioxide: Inhalation toxicology and epidemiology. Ann Occup Hyg 49(6):461–472.
  • Hsu LY, Chein HM. 2007. Evaluation of nanoparticle emission for TiO2 nanopowder coating materials. J Nanopart Res 9(1):157–163.
  • Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19 (7):975–983.
  • International Agency for Research on Cancer (IARC). 2006. Overall evaluations of carcinogenicity to humans, Group 2B: Possibly carcinogenic to humans. IARC Monogr 93(1–5).
  • Inoue K, Takano H, Ohnuki M, Yanagisawa R, Sakurai M, Shimada A, Mizushima K, Yoshikawa T. 2008. Size effects of nanomaterials on lung inflammation and coagulatory disturbance. Int J Immunopathol Pharmacol 21(1):197–206.
  • Jin CY, Zhu BS, Wang XF, Lu QH. 2008. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol 21(9):1871–1877.
  • Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Stone V. 2009. Identification of the mechanisms that drive the toxicity of TiO2 particulates; the contribution of physicochemical characteristics. Particle Fibre Toxicol 6:33.
  • Jonaitis TS, Card JW. 2010. Concerns regarding nano-sized titanium dioxide dermal penetration and toxicity study. Letter to the Editor. Toxicol Lett 192(2):268–269.
  • Kang SJ, Kim BM, Lee YJ, Chung HW. 2008. Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ Molec Mutagenesis 49(5):399–405.
  • Kim JK, Lee WK, Lee EJ, Cho YJ, Lee KH, Kim HS, Chung Y, Kim KA, Lim Y. 1999. Mechanism of silica- and titanium dioxide-induced cytotoxicity in alveolar macrophages. J Toxicol Environ Health A 58(7):437–450.
  • Kiss B, Biro T, Czifra G, Toth BI, Kertesz Z, Szikszai Z, Kiss AZ, Juhasz I, Zouboulis CC, Hunyadi J. 2008. Investigation of micronized titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells. Experim Dermatol 17(8):659–667.
  • Komatsu T, Tabata M, Kubo-Irie M, Shimizu T, Suzuki KI, Nihei Y, Takeda K. 2008. The effects of nanoparticles on mouse testis Leydig cells in vitro. Toxicol in Vitro 22(8):1825–1831.
  • L’azou B, Jorly J, On D, Sellier E, Moisan F, Fleury-Feith J, Cambar J, Brochard P, Ohayon-Court C. 2008. In vitro effects of nanoparticles on renal cells. Particle Fibre Toxicol 5:22–36.
  • Linnainmaa K, Kivipensas P, Vainio H. 1997. Toxicity and cytogenetic studies of ultrafine titanium dioxide in cultured rat liver epithelial cells. Toxicol In Vitro 11(4):329–335.
  • Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B. 2006. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): Implications for nanoparticle neurotoxicity. Environ Sci Technol 40(14):4346–4352.
  • Long TC, Tajuba J, Sama P, Saleh N, Swartz C, Parker J, Hester S, Lowry GV, Veronesi B. 2007. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect 115(11):1631–1637.
  • Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. 2007. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol 20(1):10–20.
  • National Institute for Occupational Safety and Health (NIOSH). 2005. NIOSH current intelligence bulletin: Evaluation of health hazard and recommendations for occupational exposure to titanium dioxide. Draft. Available via the website: http://www.cdc.gov/niosh/review/public/TIo2/pdfs/TIO2Draft.pdf.
  • Park EJ, Yi J, Chung KH, Ryu DY, Choi J, Park K. 2008. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicology Letters 180(3):222–229.
  • Peters K, Unger RE, Kirkpatrick CJ, Gatti AM, Monari E. 2004. Effects of nano-scaled particles on endothelial cell function in vitro: Studies on viability, proliferation and inflammation. J Materials Sci Materials Med 15(4):321–325.
  • Pflucker F, Hohenberg H, Holzle E, Will T, Pfeiffer S, Wepf R, Diembeck W, Wenck H, Gers-Barlag H. 1999. The outermost stratum corneum layer is an effective barrier against dermal uptake of topically applied micronized titanium dioxide. Int J Cosmetic Sci 21(6):399–411.
  • Renwick LC, Brown D, Clouter A, Donaldson K. 2004. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occupat Environ Med 61(5):442–447.
  • Renwick LC, Donaldson K, Clouter A. 2001. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 172(2):119–127.
  • Sager TM, Kommineni C, Castranova V. 2008. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: Role of particle surface area. Particle Fibre Toxicol 5:17.
  • Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 2007. Opinion on the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials. Scientific Committee on Emerging and Newly Identified Health Risks. 21–22 June 2007. Accessed from the website: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_010.pdf.
  • Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 2009. Risk assessment of products of Nanotechnologies. Scientific Committee on Emerging and Newly Identified Health Risks. Opinion adopted 19 January 2009. Accessed from the website: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_023.pdf.
  • Schulz J, Hohenberg H, Pflucker F, Gartner E, Will T, Pfeiffer S, Wepf R, Wendel V, Gers-Barlag H, Wittern KP. 2002. Distribution of sunscreens on skin. Adv Drug Deliv Rev 54(1):S157–163.
  • Shimizu M, Tainaka H, Oba T, Mizuo K, Umezawa M, Takeda K. 2009. Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse. Particle Fibre Toxicol 6(20).
  • Simon-Deckers A, Gouget B, Mayne-L’hermite M, Herlin-Boime N, Reynaud C, Carriere M. 2008. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 253(1–3):137–146.
  • Singh N, Manshian B, Jenkins GJS, Griffiths SM, Williams PM, Maffeis TGG, Wright CJ, Doak SH. 2009. NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials 30:3891–3914.
  • Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH. 2009. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res 69:8784.
  • Tsai S, Ada E, Isaacs JA, Ellenbecker MJ. 2009. Airborne nanoparticle exposures associated with the manual handling of nanoalumina and nanosilver in fume hoods. J Nanoparticle Res 11:147–161.
  • Wang J, Chen C, Liu Y, Jiao F, Li W, Lao F, Li Y, Li B, Ge C, Zhou G, Gao Y, Zhao Y, Chai Z. 2008a. Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 183(1–3):72–80.
  • Wang J, Liu Y, Jiao F, Lao F, Li W, Gu Y, Li Y, Ge C, Zhou G, Li B, Zhao Y, Chai Z, Chen C. 2008b. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology 254(1–2):82–90.
  • Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, Jia G, Gao Y, Li B, Sun J, Li Y, Jiao F, Zhao Y, Chai Z. 2007. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168(2):176–185.
  • Warheit DB, Webb T R, Reed KL, Frerichs S, Sayes CM. 2007a. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: Differential responses related to surface properties. Toxicology 230(1):90–104.
  • Warheit DB, Hoke RA, Finlay C, Maria Donner E, Reed KL, Sayes M. 2007b. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 171:99–110.
  • Wu J, Wei L, Chenbing X, Zhou S, Lan F, Bi H, Yang X, Zeng F-D. 2009. Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett 191:1–8.
  • Yokohira M, Hashimimoto N, Yamakawa K, Suzuki S, Saoo K, Kuno T, Imaida K. 2009. Lung carcinogenic bioassay of CuO and TiO2 nanoparticles with intratracheal instillation using F344 male rats. J Toxicol. Pathol 22:71–78.
  • Zhang AP, Sun YP. 2004. Photocatalytic killing effect of TiO2 nanoparticles on Ls-174-t human colon carcinoma cells. World J Gastroenterol 10(21):3191–3193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.